Evaluation of efficacy of antiviral therapy for chronic hepatitis C: a EUROHEP Consensus Report on response criteria

scientific article published in September 1996

Evaluation of efficacy of antiviral therapy for chronic hepatitis C: a EUROHEP Consensus Report on response criteria is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2893.1996.TB00055.X
P698PubMed publication ID8914009

P2093author name stringAlmasio P
Craxì A
Schalm S
P2860cites workChronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alphaQ27473012
Pretreatment viral load and response to prolonged interferon-α course for chronic hepatitis CQ43038335
Prediction of response to interferon treatment of chronic hepatitis C.Q43041709
Hepatitis C serotype and response to interferon therapy.Q43048820
Factors predictive of response to interferon-alpha therapy in hepatitis C virus infectionQ43049113
Reliability of polymerase chain reaction for detection of hepatitis C virusQ43049524
Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatmentQ44203363
Interferon and hepatitis C.Q49203187
Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis CQ58622903
Interferon-α for chronic hepatitis C: An analysis of pretreatment clinical predictors of response,Q58803515
P433issue5
P304page(s)273-276
P577publication date1996-09-01
P1433published inJournal of Viral HepatitisQ15749962
P1476titleEvaluation of efficacy of antiviral therapy for chronic hepatitis C: a EUROHEP Consensus Report on response criteria
P478volume3

Reverse relations

cites work (P2860)
Q33809532Definition of response to antiviral therapy in chronic hepatitis C.
Q43674745Interferon-alpha plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study
Q33940500Methodological issues in papers on IFN therapy: time for reappraisal.
Q33809555New treatment strategies in non-responder patients with chronic hepatitis C.

Search more.